- Home
- HOV vs OCUL Comparison
HOV vs OCUL Comparison
Compare HOV & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOV
- OCUL
- Stock Information
- Founded
- HOV 1959
- OCUL 2006
- Country
- HOV United States
- OCUL United States
- Employees
- HOV N/A
- OCUL N/A
- Industry
- HOV Homebuilding
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- HOV Consumer Discretionary
- OCUL Health Care
- Exchange
- HOV Nasdaq
- OCUL Nasdaq
- Market Cap
- HOV 843.6M
- OCUL 957.3M
- IPO Year
- HOV N/A
- OCUL 2014
- Fundamental
- Price
- HOV $97.74
- OCUL $7.90
- Analyst Decision
- HOV Sell
- OCUL Strong Buy
- Analyst Count
- HOV 2
- OCUL 10
- Target Price
- HOV $155.00
- OCUL $16.22
- AVG Volume (30 Days)
- HOV 89.1K
- OCUL 1.8M
- Earning Date
- HOV 05-21-2025
- OCUL 05-06-2025
- Dividend Yield
- HOV N/A
- OCUL N/A
- EPS Growth
- HOV 18.84
- OCUL N/A
- EPS
- HOV 32.36
- OCUL N/A
- Revenue
- HOV $3,084,345,000.00
- OCUL $63,723,000.00
- Revenue This Year
- HOV N/A
- OCUL $13.32
- Revenue Next Year
- HOV $5.54
- OCUL $13.13
- P/E Ratio
- HOV $3.14
- OCUL N/A
- Revenue Growth
- HOV 8.80
- OCUL 9.03
- 52 Week Low
- HOV $81.15
- OCUL $4.06
- 52 Week High
- HOV $240.34
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- HOV 45.57
- OCUL 56.28
- Support Level
- HOV $90.95
- OCUL $6.94
- Resistance Level
- HOV $105.00
- OCUL $8.23
- Average True Range (ATR)
- HOV 8.48
- OCUL 0.64
- MACD
- HOV 0.76
- OCUL 0.13
- Stochastic Oscillator
- HOV 50.99
- OCUL 83.54
About HOV Hovnanian Enterprises Inc.
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.